{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:08:08Z","timestamp":1787497688033,"version":"build-2736575974"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006259","name":"Teva Pharmaceutical Industries","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006259","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000887","name":"Huntington's Disease Society of America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000887","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005725","name":"CHDI Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008893","name":"University of Iowa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008893","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016012","name":"Huntington's Disease Society of America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016012","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.sleep.2025.02.032","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T11:29:17Z","timestamp":1741087757000},"page":"238-244","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Melatonin for Huntington's Disease (HD) gene carriers with HD-related sleep disturbance - A pilot study"],"prefix":"10.1016","volume":"129","author":[{"given":"Shayan A.","family":"Zadegan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Karagas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Will","family":"Tanigaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepa","family":"Dongarwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Patino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2616-8082","authenticated-orcid":false,"given":"Natalia P.","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Furr Stimming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.sleep.2025.02.032_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2015.5","article-title":"Huntington disease","volume":"1","author":"Bates","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.sleep.2025.02.032_bib2","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1177\/1039856218791036","article-title":"Huntington's disease: neuropsychiatric manifestations of Huntington's disease","volume":"26","author":"Goh","year":"2018","journal-title":"Australas Psychiatry"},{"key":"10.1016\/j.sleep.2025.02.032_bib3","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3233\/JHD-200434","article-title":"Sleep dysfunction in Huntington's disease: perspectives from patients","volume":"9","author":"Tanigaki","year":"2020","journal-title":"J Huntingtons Dis"},{"key":"10.1016\/j.sleep.2025.02.032_bib4","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsz154","article-title":"Sleep in Huntington's disease: a systematic review and meta-analysis of polysomongraphic findings","volume":"42","author":"Zhang","year":"2019","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2025.02.032_bib5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3233\/JHD-230576","article-title":"Sleep disorders and circadian disruption in Huntington's disease","volume":"12","author":"Saade-Lemus","year":"2023","journal-title":"J Huntingtons Dis"},{"key":"10.1016\/j.sleep.2025.02.032_bib6","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3233\/JHD-230567","article-title":"Sleep dysfunction in Huntington's disease: impacts of current medications and prospects for treatment","volume":"12","author":"Owen","year":"2023","journal-title":"J Huntingtons Dis"},{"key":"10.1016\/j.sleep.2025.02.032_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/jpm12060864","article-title":"Sleep quality and related clinical manifestations in Huntington disease","volume":"12","author":"Maffi","year":"2022","journal-title":"J Pers Med"},{"key":"10.1016\/j.sleep.2025.02.032_bib8","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1007\/s00415-009-5196-1","article-title":"Delayed onset of the diurnal melatonin rise in patients with Huntington's disease","volume":"256","author":"Aziz","year":"2009","journal-title":"J Neurol"},{"key":"10.1016\/j.sleep.2025.02.032_bib9","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1002\/mds.26003","article-title":"Plasma melatonin is reduced in Huntington's disease","volume":"29","author":"Kalliolia","year":"2014","journal-title":"Mov Disord"},{"key":"10.1016\/j.sleep.2025.02.032_bib10","doi-asserted-by":"crossref","first-page":"14496","DOI":"10.1523\/JNEUROSCI.3059-11.2011","article-title":"The melatonin MT1 receptor axis modulates mutant Huntingtin-mediated toxicity","volume":"31","author":"Wang","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.sleep.2025.02.032_bib11","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.brainres.2005.03.053","article-title":"Melatonin protects against neuronal damage induced by 3-nitropropionic acid in rat striatum","volume":"1046","author":"Nam","year":"2005","journal-title":"Brain Res"},{"key":"10.1016\/j.sleep.2025.02.032_bib12","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.2174\/1871527313666140806160400","article-title":"The role of melatonin in multiple sclerosis, Huntington's disease and cerebral ischemia","volume":"13","author":"Escribano","year":"2014","journal-title":"CNS Neurol Disord: Drug Targets"},{"key":"10.1016\/j.sleep.2025.02.032_bib13","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2217\/nmt.15.45","article-title":"Therapeutic strategies for circadian rhythm and sleep disturbances in Huntington disease","volume":"5","author":"van Wamelen","year":"2015","journal-title":"Neurodegener Dis Manag"},{"key":"10.1016\/j.sleep.2025.02.032_bib14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00415-020-10381-w","article-title":"Effect of melatonin supplementation on sleep quality: a systematic review and meta-analysis of randomized controlled trials","volume":"269","author":"Fatemeh","year":"2022","journal-title":"J Neurol"},{"key":"10.1016\/j.sleep.2025.02.032_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c332","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Schulz","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.sleep.2025.02.032_bib16","article-title":"CONSORT 2010 statement: extension to randomised crossover trials","volume":"366","author":"Dwan","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.sleep.2025.02.032_bib17","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.sleep.2025.02.032_bib18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","article-title":"The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research","volume":"28","author":"Buysse","year":"1989","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.sleep.2025.02.032_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/currents.RRN1189","article-title":"Identifying sleep disturbances in Huntington's disease using a simple disease-focused questionnaire","volume":"2","author":"Goodman","year":"2010","journal-title":"PLoS Curr"},{"key":"10.1016\/j.sleep.2025.02.032_bib20","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","article-title":"A new method for measuring daytime sleepiness: the Epworth sleepiness scale","volume":"14","author":"Johns","year":"1991","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2025.02.032_bib21","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.sleep.2025.02.032_bib22","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1212\/WNL.0b013e318258f744","article-title":"Neuro-QOL: brief measures of health-related quality of life for clinical research in neurology","volume":"78","author":"Cella","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.sleep.2025.02.032_bib23","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","article-title":"The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia","volume":"44","author":"Cummings","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.sleep.2025.02.032_bib24","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The hospital anxiety and depression scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.sleep.2025.02.032_bib25","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mds.870110204","article-title":"Reliability and consistency. Huntington Study Group","volume":"11","year":"1996","journal-title":"Mov Disord"},{"key":"10.1016\/j.sleep.2025.02.032_bib26","series-title":"ECDEU assessment manual for psychopharmacology, rev. 1976. Rockville, Md: U.S. Dept. Of Health, education, and welfare, public Health service, alcohol, drug abuse, and mental Health administration","author":"Guy","year":"1976"},{"key":"10.1016\/j.sleep.2025.02.032_bib27","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1093\/sleep\/26.7.893","article-title":"A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease","volume":"26","author":"Singer","year":"2003","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2025.02.032_bib28","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/JGP.0b013e318187de18","article-title":"Melatonin fails to improve sleep or agitation in double-blind randomized placebo-controlled trial of institutionalized patients with Alzheimer disease","volume":"17","author":"Gehrman","year":"2009","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.sleep.2025.02.032_bib29","first-page":"947","article-title":"Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer's disease: a 6-month, randomized, placebo-controlled, multicenter trial","volume":"9","author":"Wade","year":"2014","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.sleep.2025.02.032_bib30","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.sleep.2005.04.004","article-title":"Melatonin for sleep disturbances in Parkinson's disease","volume":"6","author":"Dowling","year":"2005","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2025.02.032_bib31","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00415-006-0390-x","article-title":"Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson's disease. A randomized, double blind, placebo-controlled study","volume":"254","author":"Medeiros","year":"2007","journal-title":"J Neurol"},{"key":"10.1016\/j.sleep.2025.02.032_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110485","article-title":"Effect of melatonin administration on the PER1 and BMAL1 clock genes in patients with Parkinson's disease","volume":"129","author":"Delgado-Lara","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.sleep.2025.02.032_bib33","article-title":"Melatonin supplementation and the effects on clinical and metabolic status in Parkinson's disease: a randomized, double-blind, placebo-controlled trial","volume":"195","author":"Daneshvar","year":"2020","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.sleep.2025.02.032_bib34","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.parkreldis.2020.03.029","article-title":"Prolonged-release melatonin in Parkinson's disease patients with a poor sleep quality: a randomized trial","volume":"75","author":"Ahn","year":"2020","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.sleep.2025.02.032_bib35","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.nrl.2018.08.002","article-title":"Insomnia study group of the Spanish sleep society (SES). Melatonin in sleep disorders","volume":"37","author":"Poza","year":"2022","journal-title":"Neurologia"},{"key":"10.1016\/j.sleep.2025.02.032_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.smrv.2021.101431","article-title":"Pharmacokinetics of exogenous melatonin in relation to formulation, and effects on sleep: a systematic review","volume":"57","author":"Moroni","year":"2021","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.sleep.2025.02.032_bib37","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00228-015-1873-4","article-title":"Clinical pharmacokinetics of melatonin: a systematic review","volume":"71","author":"Harps\u00f8e","year":"2015","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.sleep.2025.02.032_bib38","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1210\/er.2018-00084","article-title":"Melatonin as a hormone: new physiological and clinical insights","volume":"39","author":"Cipolla-Neto","year":"2018","journal-title":"Endocr Rev"},{"key":"10.1016\/j.sleep.2025.02.032_bib39","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1177\/0748730405277492","article-title":"Melatonin: characteristics, concerns, and prospects","volume":"20","author":"Arendt","year":"2005","journal-title":"J Biol Rhythms"},{"key":"10.1016\/j.sleep.2025.02.032_bib40","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1037\/pas0000128","article-title":"The Pittsburgh Sleep Quality Index: validity and factor structure in young people","volume":"27","author":"de la Vega","year":"2015","journal-title":"Psychol Assess"},{"key":"10.1016\/j.sleep.2025.02.032_bib41","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1159\/000480701","article-title":"Subjective assessment of sleep in Huntington disease: reliability of sleep questionnaires compared to polysomnography","volume":"17","author":"Piano","year":"2017","journal-title":"Neurodegener Dis"},{"key":"10.1016\/j.sleep.2025.02.032_bib42","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12985","article-title":"Optimizing the time and dose of melatonin as a sleep-promoting drug: a systematic review of randomized controlled trials and dose-response meta-analysis","volume":"76","author":"Cruz-Sanabria","year":"2024","journal-title":"J Pineal Res"}],"container-title":["Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945725000838?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945725000838?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:57:37Z","timestamp":1762545457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1389945725000838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":42,"alternative-id":["S1389945725000838"],"URL":"https:\/\/doi.org\/10.1016\/j.sleep.2025.02.032","relation":{},"ISSN":["1389-9457"],"issn-type":[{"value":"1389-9457","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Melatonin for Huntington's Disease (HD) gene carriers with HD-related sleep disturbance - A pilot study","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sleep.2025.02.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}